Skip to main content

Kinney Gene G.'s Form 4 filing

Prothena Corp Public Ltd Co (PRTA) · filed Aug 12, 2022

Accession no.
0001140361-22-029517
Filed
Aug 12, 2022
Trade date
Aug 10-12, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.12M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kinney Gene G.CIK 0001564380Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 10, 2022Ordinary Shares, par value $0.01 per shareMOption exerciseAcquired+991$6.41+$6,352.3113,784Direct
Aug 10, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−991$32.01F2−$31,721.9112,793Direct
Aug 11, 2022Ordinary Shares, par value $0.01 per shareMOption exerciseAcquired+13,650$6.41+$87,496.526,443Direct
Aug 11, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−13,650$32.16F3−$438,98412,793Direct
Aug 12, 2022Ordinary Shares, par value $0.01 per shareMOption exerciseAcquired+20,284$6.41+$130,020.4433,077Direct
Aug 12, 2022Ordinary Shares, par value $0.01 per shareSSaleDisposed−20,284$32.16F4−$652,333.4412,793Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 10, 2022Ordinary SharesMOption exerciseDisposed−991$0.00$055,247Direct
Aug 11, 2022Ordinary SharesMOption exerciseDisposed−13,650$0.00$041,597Direct
Aug 12, 2022Ordinary SharesMOption exerciseDisposed−20,284$0.00$021,313Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction was executed in multiple trades in prices ranging from $32.00 to $32.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The transaction was executed in multiple trades in prices ranging from $32.00 to $32.325, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades in prices ranging from $32.00 to $32.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)